Supporting Patients with T2D and Control-IQ+ Technology

Nov 3, 2026

What you’ll learn:

  • When AID technology is paired with glucose-lowering medications, like GLP-1s, patients see an additive impact

  • Simplified bolusing strategies help HCPs meet their type 2 patients where they are and remove a long-standing barrier to pump technology

  • The unique Control-IQ+ technology feature, AutoBolus, means that simplified bolusing strategies can be a useful tool for all patients living with diabetes